CONTROLLED RELEASE NITAZOXANIDE IN COMBINATION WITH PEGINTERFERON ALFA-2A PLUS RIBAVIRIN RESULTS IN HIGH EARLY VIROLOGIC RESPONSE RATES FOR TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 4

被引：0
|
作者：
Keeffe, Emmet B. [1 ,2 ]
Elfert, Asem [3 ]
Abousail, Sabry [3 ]
Rossignol, Jean-Francois [1 ,2 ]
机构：
[1] Romark Inst Med Res, Romark Labs, Tampa, FL USA
[2] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA
[3] Tanta Univ, Dept Gastroenterol & Hepatol, Tanta, Egypt
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1588
引用
收藏
页码：1038A / 1038A
页数：1
相关论文
共 50 条
  • [1] DOSE-RELATED INCREASE IN VIROLOGIC RESPONSES USING CONTROLLED RELEASE NITAZOXANIDE PLUS PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 4: FINAL REPORT
    Keeffe, E. B.
    Elfert, A. A.
    Abousaif, S. A.
    [J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S479 - S480
  • [2] Chronic hepatitis C genotype 4:: Efficacy and safety of the treatment with peginterferon alfa-2a plus ribavirin
    Diago, M.
    Boadas, J.
    Planas, R.
    Sola, R.
    del Olmo, J. A.
    Crespo, J.
    Erdozain, J. C.
    Anton, M. D.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S292 - S292
  • [3] Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin
    Rossignol, Jean-Francois
    Elfert, Asem
    El-Gohary, Yehia
    Keeffe, Emmet B.
    [J]. GASTROENTEROLOGY, 2009, 136 (03) : 856 - 862
  • [4] Impact of gender on virologic responses rates in genotype 1 chronic hepatitis C patients with peginterferon alfa-2a and ribavirin treatment
    Yu, J. -W.
    Sun, L. -J.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S86 - S86
  • [5] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C
    Rakov, NE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 259 - 260
  • [6] Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
    Davis, GL
    Wong, JB
    McHutchison, JG
    Manns, MP
    Harvey, J
    Albrecht, J
    [J]. HEPATOLOGY, 2003, 38 (03) : 645 - 652
  • [7] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C - Reply
    Fried, MW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 260 - 260
  • [8] A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
    Swain, Mark G.
    Lai, Ming-Yang
    Shiffman, Mitchell L.
    Cooksley, W. Graham E.
    Zeuzem, Stefan
    Dieterich, Douglas T.
    Abergel, Armand
    Pessoa, Mario G.
    Lin, Amy
    Tietz, Andreas
    Connell, Edward V.
    Diago, Moises
    [J]. GASTROENTEROLOGY, 2010, 139 (05) : 1593 - 1601
  • [9] Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Al-Ajmi, M
    Owaid, S
    Varghese, R
    Al-Nakib, B
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1733 - 1737
  • [10] Randomized controlled trial of nitazoxanide-peginterferon-ribavirin, nitazoxanide-peginterferon and peginterferon-ribavirin in the treatment of patients with chronic hepatitis C genotype 4
    Rossignol, J. F.
    Elfert, A.
    El-Gohary, Y.
    Keeffe, E. B.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S30 - S30
12345